Klausa, F.; Świątoniowska-Lonc, N.; Skotny, A.; Mak, M.A.; Wysokińska-Kordybach, A.; Skiba, J.; Ściborski, K.; Banasiak, W.; Doroszko, A.
Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review. J. Clin. Med. 2026, 15, 4113.
https://doi.org/10.3390/jcm15114113
AMA Style
Klausa F, Świątoniowska-Lonc N, Skotny A, Mak MA, Wysokińska-Kordybach A, Skiba J, Ściborski K, Banasiak W, Doroszko A.
Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review. Journal of Clinical Medicine. 2026; 15(11):4113.
https://doi.org/10.3390/jcm15114113
Chicago/Turabian Style
Klausa, Filip, Natalia Świątoniowska-Lonc, Anna Skotny, Marek A. Mak, Agnieszka Wysokińska-Kordybach, Jacek Skiba, Krzysztof Ściborski, Waldemar Banasiak, and Adrian Doroszko.
2026. "Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review" Journal of Clinical Medicine 15, no. 11: 4113.
https://doi.org/10.3390/jcm15114113
APA Style
Klausa, F., Świątoniowska-Lonc, N., Skotny, A., Mak, M. A., Wysokińska-Kordybach, A., Skiba, J., Ściborski, K., Banasiak, W., & Doroszko, A.
(2026). Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review. Journal of Clinical Medicine, 15(11), 4113.
https://doi.org/10.3390/jcm15114113
